Heinemann V, von Weikersthal LF, Decker T, Kiani A, et al. FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial. Br J Cancer 2020 Nov 6. pii: 10.1038/s41416-020-01140.
PMID: 33154570